speb/financial-data huggingface dataset:
DuPont ROE decomposition for CRNX (annual period ending 2024-12-31)
ROE: -32.019554581737005%
Net margin: -28720.692974013473%
Asset turnover: 0.0010038914077427179
Equity multiplier (leverage): 1.1105385396620333
EBIT margin: -32613.474494706446%
ROE archetype: Low Return
DuPont ROE decomposition for CRNX (annual period ending 2025-12-31)
ROE: -40.16741422114492%
Net margin: -37250.753987996635%
Asset turnover: 0.0009755732337205357
Equity multiplier (leverage): 1.1052968464595612
EBIT margin: -11027.597557365245%
ROE archetype: Low Return
DuPont ROE decomposition for CRST.L (annual period ending 2022-10-31)
ROE: 2.989468916317518%
Net margin: 2.8896672504378285%
Asset turnover: 0.5785207700101317
Equity multiplier (leverage): 1.7882459517608424
EBIT margin: 4.619089316987741%
Interest burden factor: 0.7772511848341233
Tax burden factor: 0.8048780487804877
ROE archetype: Low Return
DuPont ROE decomposition for CRST.L (annual period ending 2023-10-31)
ROE: 2.107958591225284%
Net margin: 2.7224334600760454%
Asset turnover: 0.4331287375497989
Equity multiplier (leverage): 1.787671851892425
EBIT margin: 4.517110266159696%
Interest burden factor: 0.7777777777777779
Tax burden factor: 0.7748917748917749
ROE archetype: Low Return
DuPont ROE decomposition for CRST.L (annual period ending 2024-10-31)
ROE: -13.75618009571809%
Net margin: -16.98479456486574%
Asset turnover: 0.43038315361930507
Equity multiplier (leverage): 1.8818382474530697
EBIT margin: -21.17437722419929%
ROE archetype: Low Return
DuPont ROE decomposition for CRST.L (annual period ending 2025-10-31)
ROE: 0.3074306942507375%
Net margin: 0.3601833660772757%
Asset turnover: 0.43045106588615173
Equity multiplier (leverage): 1.9828953111374663
EBIT margin: 4.7314996725605765%
Interest burden factor: 0.10034602076124567
Tax burden factor: 0.7586206896551724
ROE archetype: Low Return
DuPont ROE decomposition for CRWC.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0103356661482634
ROE archetype: Standard Business
DuPont ROE decomposition for CRWC.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0082097581567575
ROE archetype: Standard Business
DuPont ROE decomposition for CSC.L (annual period ending 2022-09-30)
ROE: -33.355366438073204%
Net margin: -16.18749749388508%
Asset turnover: 0.903652438582506
Equity multiplier (leverage): 2.280261092291168
EBIT margin: -10.926661052969244%
ROE archetype: Low Return
DuPont ROE decomposition for CSC.L (annual period ending 2023-09-30)
ROE: -5.517369647514927%
Net margin: -3.2854308801470946%
Asset turnover: 0.7935288340689711
Equity multiplier (leverage): 2.116299037642889
EBIT margin: 5.709585329268883%
Interest burden factor: -0.2364406779661017
ROE archetype: Low Return
DuPont ROE decomposition for CSC.L (annual period ending 2024-09-30)
ROE: -20.663732736620492%
Net margin: -16.436231199838137%
Asset turnover: 0.6043338759583959
Equity multiplier (leverage): 2.080317369058895
EBIT margin: -11.27672489377487%
ROE archetype: Low Return
DuPont ROE decomposition for CSC.L (annual period ending 2025-09-30)
ROE: -3.243512669246003%
Net margin: -2.1347162757040343%
Asset turnover: 0.797253227137603
Equity multiplier (leverage): 1.9058080255864895
EBIT margin: 0.2593016945064222%
Interest burden factor: -18.813953488372096
ROE archetype: Low Return
DuPont ROE decomposition for CSTE (quarterly period ending 2025-03-31)
ROE: -4.926730188845239%
Net margin: -12.937182345969184%
Asset turnover: 0.18458201234773902
Equity multiplier (leverage): 2.06314476860051
EBIT margin: -11.377287611241687%
ROE archetype: Low Return
DuPont ROE decomposition for CSTE (quarterly period ending 2025-06-30)
ROE: -7.588153176061296%
Net margin: -18.347952493498017%
Asset turnover: 0.19738311551115267
Equity multiplier (leverage): 2.095262703505379
EBIT margin: -10.496128477201031%
ROE archetype: Low Return
DuPont ROE decomposition for CSTE (quarterly period ending 2025-09-30)
ROE: -7.653646457101601%
Net margin: -17.712903478533374%
Asset turnover: 0.20055673200498483
Equity multiplier (leverage): 2.154474690817108
EBIT margin: -11.78705734879348%
ROE archetype: Low Return
DuPont ROE decomposition for CSTE (quarterly period ending 2025-12-31)
ROE: -48.87314303403325%
Net margin: -93.11801768412136%
Asset turnover: 0.2145290526029978
Equity multiplier (leverage): 2.4465293632235174
EBIT margin: -18.450786255096098%
ROE archetype: Low Return
DuPont ROE decomposition for CSTE (quarterly period ending 2026-03-31)
ROE: -16.446099095028245%
Net margin: -23.79014530656416%
Asset turnover: 0.23159560577009658
Equity multiplier (leverage): 2.9849392254418894
EBIT margin: -12.165620173826783%
ROE archetype: Low Return
DuPont ROE decomposition for CSTL (annual period ending 2022-12-31)
ROE: -16.820243016409872%
Net margin: -48.991892818832596%
Asset turnover: 0.3063494653823025
Equity multiplier (leverage): 1.120703995991482
EBIT margin: -66.50807434379993%
ROE archetype: Low Return
DuPont ROE decomposition for CSTL (annual period ending 2023-12-31)
ROE: -14.540642368161697%
Net margin: -26.14610442790325%
Asset turnover: 0.4880549902350364
Equity multiplier (leverage): 1.1394829830760647
EBIT margin: -30.928440133219283%
ROE archetype: Low Return
DuPont ROE decomposition for CSTL (annual period ending 2024-12-31)
ROE: 4.307617482623149%
Net margin: 5.494340031740391%
Asset turnover: 0.6745428230454765
Equity multiplier (leverage): 1.1622834976579026
EBIT margin: 2.610903155669454%
Interest burden factor: 2.48719723183391
Tax burden factor: 0.8460860693748841
ROE archetype: Low Return
DuPont ROE decomposition for CSTL (annual period ending 2025-12-31)
ROE: -5.213724279924205%
Net margin: -7.018002550627635%
Asset turnover: 0.6203492369283946
Equity multiplier (leverage): 1.197562770581456
EBIT margin: -12.436488500387822%
ROE archetype: Low Return
DuPont ROE decomposition for CSV (annual period ending 2022-12-31)
ROE: 30.175594673822687%
Net margin: 11.17879699816843%
Asset turnover: 0.310301353786831
Equity multiplier (leverage): 8.699155570463926
EBIT margin: 22.085559763786762%
Interest burden factor: 0.6995780074613174
Tax burden factor: 0.7235199496450677
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSV (annual period ending 2023-12-31)
ROE: 21.54329226226168%
Net margin: 8.73496810624281%
Asset turnover: 0.3108652491952465
Equity multiplier (leverage): 7.933751136385617
EBIT margin: 21.481229739621458%
Interest burden factor: 0.5650359011804795
Tax burden factor: 0.7196579723879472
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSV (annual period ending 2024-12-31)
ROE: 17.27051177904143%
Net margin: 8.152687544223376%
Asset turnover: 0.3173127045036332
Equity multiplier (leverage): 6.676009538534106
EBIT margin: 20.875659948836955%
Interest burden factor: 0.5935126038469287
Tax burden factor: 0.6580071884984026
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSV (annual period ending 2025-12-31)
ROE: 22.233589308607762%
Net margin: 12.338779225756994%
Asset turnover: 0.3179907712289348
Equity multiplier (leverage): 5.666604075747961
EBIT margin: 23.483135300881564%
Interest burden factor: 0.7167645978699964
Tax burden factor: 0.7330600742923018
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTBI (quarterly period ending 2025-03-31)
ROE: 2.8019363098911976%
Net margin: 33.20839127017713%
Asset turnover: 0.0105415136226806
Equity multiplier (leverage): 8.004006774024067
Tax burden factor: 0.7739890094406087
ROE archetype: Low Return
DuPont ROE decomposition for CTBI (quarterly period ending 2025-06-30)
ROE: 3.129900486536802%
Net margin: 35.46310407201151%
Asset turnover: 0.011085256581905633
Equity multiplier (leverage): 7.961740772236542
Tax burden factor: 0.7672089726998212
ROE archetype: Low Return
DuPont ROE decomposition for CTBI (quarterly period ending 2025-09-30)
ROE: 2.919104747650225%
Net margin: 33.441958041958046%
Asset turnover: 0.010975459716340395
Equity multiplier (leverage): 7.953078360828254
Tax burden factor: 0.7740692780835222
ROE archetype: Low Return
DuPont ROE decomposition for CTBI (quarterly period ending 2025-12-31)
ROE: 3.232816476981472%
Net margin: 36.50428265524625%
Asset turnover: 0.011217310086939408
Equity multiplier (leverage): 7.894934057110009
Tax burden factor: 0.7713800904977376
ROE archetype: Low Return
DuPont ROE decomposition for CTBI (quarterly period ending 2026-03-31)
ROE: 3.1484666682490823%
Net margin: 36.648875950185996%
Asset turnover: 0.011053155883374279
Equity multiplier (leverage): 7.772346361437999
Tax burden factor: 0.7692655878691864
ROE archetype: Low Return
DuPont ROE decomposition for CTE.AX (annual period ending 2022-06-30)
ROE: 28.05695692003414%
Net margin: 11.600309606739902%
Asset turnover: 0.479821076735172
Equity multiplier (leverage): 5.040709435238514
EBIT margin: 16.09322224915687%
Interest burden factor: 0.9547354835163442
Tax burden factor: 0.7549940129970278
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTE.AX (annual period ending 2023-06-30)
ROE: 35.92518536232019%
Net margin: 11.805613741097613%
Asset turnover: 0.49560382084856064
Equity multiplier (leverage): 6.140105056896737
EBIT margin: 12.769166317553415%
Interest burden factor: 1.0334645669291338
Tax burden factor: 0.8946031746031746
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTE.AX (annual period ending 2024-06-30)
ROE: 87.35747108547571%
Net margin: 14.589280050745323%
Asset turnover: 0.597583229743793
Equity multiplier (leverage): 10.020001603523982
EBIT margin: 16.286076752299397%
Interest burden factor: 1.0155793573515093
Tax burden factor: 0.8820709491850431
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTE.AX (annual period ending 2025-06-30)
ROE: 97.44037983128952%
Net margin: 13.346557098328137%
Asset turnover: 0.7134470825543588
Equity multiplier (leverage): 10.233117316355399
EBIT margin: 17.682062907339187%
Interest burden factor: 1.0108173076923077
Tax burden factor: 0.746730083234245
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTE.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.2006647229396763
ROE archetype: Standard Business
DuPont ROE decomposition for CTE.NS (quarterly period ending 2024-12-31)
Net margin: -8.593168424317618%
EBIT margin: -4.871277915632755%
ROE archetype: Standard Business
DuPont ROE decomposition for CTE.NS (quarterly period ending 2025-03-31)
ROE: -9.172069201504126%
Net margin: -12.33368494590246%
Asset turnover: 0.2577507694913145
Equity multiplier (leverage): 2.885190554333189
EBIT margin: -11.626369755249947%
ROE archetype: Low Return
DuPont ROE decomposition for CTE.NS (quarterly period ending 2025-06-30)
Net margin: 1.183209448167189%
EBIT margin: -0.7035191876104222%
Tax burden factor: 0.5658958987534494
ROE archetype: Standard Business
DuPont ROE decomposition for CTE.NS (quarterly period ending 2025-09-30)
ROE: -7.6883700826546235%
Net margin: -11.815756003890373%
Asset turnover: 0.2444150515994042
Equity multiplier (leverage): 2.6622253758403023
EBIT margin: -7.338655010666782%
ROE archetype: Low Return
DuPont ROE decomposition for CTE.NS (quarterly period ending 2025-12-31)
Net margin: 2.6777296273412765%
EBIT margin: 7.859163180095223%
Interest burden factor: 0.44043959631130813
Tax burden factor: 0.7735779136557347
ROE archetype: Standard Business
DuPont ROE decomposition for CTE.NS (quarterly period ending 2026-03-31)
ROE: 4.779121762347807%
Net margin: 9.63191983931755%
Asset turnover: 0.21562507096504901
Equity multiplier (leverage): 2.301102587135737
EBIT margin: 11.33001838018651%
Interest burden factor: 0.8908020538243626
Tax burden factor: 0.954335403726708
ROE archetype: Low Return
DuPont ROE decomposition for CTEK.V (quarterly period ending 2025-03-31)
ROE: 23.972237052856357%
Net margin: 12.118758434547908%
Asset turnover: 0.24387835703001576
Equity multiplier (leverage): 8.111051788574471
EBIT margin: 19.70310391363023%
Interest burden factor: 0.6452054794520549
Tax burden factor: 0.9532908704883227
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTEK.V (quarterly period ending 2025-06-30)
ROE: -26.268801903705313%
Net margin: -13.633651551312651%
Asset turnover: 0.23044473743989016
Equity multiplier (leverage): 8.361058855686597
EBIT margin: 7.279236276849642%
Interest burden factor: -1.7827868852459017
ROE archetype: Low Return
DuPont ROE decomposition for CTEK.V (quarterly period ending 2025-09-30)
ROE: 19.1585554805133%
Net margin: 10.72516758074345%
Asset turnover: 0.22429355491621428
Equity multiplier (leverage): 7.964194906837237
EBIT margin: 10.694698354661792%
Interest burden factor: 1.0626780626780625
Tax burden factor: 0.9436997319034853
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTEK.V (quarterly period ending 2025-12-31)
ROE: 26.099855418067104%
Net margin: 17.513134851138354%
Asset turnover: 0.23798164316946047
Equity multiplier (leverage): 6.262255040026037
EBIT margin: 24.868651488616468%
Interest burden factor: 0.7288732394366197
Tax burden factor: 0.966183574879227
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTEK.V (quarterly period ending 2026-03-31)
ROE: 7.486828983288171%
Net margin: 6.175298804780877%
Asset turnover: 0.23657357561152279
Equity multiplier (leverage): 5.124762015090006
EBIT margin: 12.8628343767786%
Interest burden factor: 0.5110619469026548
Tax burden factor: 0.9393939393939394
ROE archetype: Standard Business
DuPont ROE decomposition for CTN.V (quarterly period ending 2025-01-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CTN.V (quarterly period ending 2025-04-30)
Asset turnover: 0
Tax burden factor: 1.1299778912028824
ROE archetype: Standard Business
DuPont ROE decomposition for CTN.V (quarterly period ending 2025-07-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CTN.V (quarterly period ending 2025-10-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CTN.V (quarterly period ending 2026-01-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CTN.V (quarterly period ending 2026-04-30)
Asset turnover: 0
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CTOR (quarterly period ending 2025-03-31)
ROE: -21.70308859345741%
Asset turnover: 0
Equity multiplier (leverage): 2.565449291174681
ROE archetype: Low Return
DuPont ROE decomposition for CTOR (quarterly period ending 2025-06-30)
ROE: -15.784576681447804%
Asset turnover: 0
Equity multiplier (leverage): 2.691754511960479
ROE archetype: Low Return
DuPont ROE decomposition for CTOR (quarterly period ending 2025-09-30)
ROE: -12.933958085395988%
Asset turnover: 0
Equity multiplier (leverage): 2.493419974988657
ROE archetype: Low Return
DuPont ROE decomposition for CTOR (quarterly period ending 2025-12-31)
ROE: -10.716639511342823%
Net margin: -140.31220216672403%
Asset turnover: 0.037399776528400576
Equity multiplier (leverage): 2.042180730715431
EBIT margin: -133.16755030474548%
ROE archetype: Low Return
DuPont ROE decomposition for CTOR (quarterly period ending 2026-03-31)
ROE: -56.808269465995075%
Net margin: -1595.9771438579066%
Asset turnover: 0.015828334636477173
Equity multiplier (leverage): 2.2487939739419764
EBIT margin: -1716.1656164644833%
ROE archetype: Low Return
DuPont ROE decomposition for CTSH (quarterly period ending 2025-03-31)
ROE: 4.44996308477079%
Net margin: 12.961876832844574%
Asset turnover: 0.25617268493013473
Equity multiplier (leverage): 1.340157057520639
EBIT margin: 15.464320625610947%
Interest burden factor: 1.102402022756005
Tax burden factor: 0.7603211009174312
ROE archetype: Low Return
DuPont ROE decomposition for CTSH (quarterly period ending 2025-06-30)
ROE: 4.27336270580051%
Net margin: 12.297426120114395%
Asset turnover: 0.26139393486332263
Equity multiplier (leverage): 1.329413323616126
EBIT margin: 15.5767397521449%
Interest burden factor: 1.0305997552019583
Tax burden factor: 0.7660332541567696
ROE archetype: Low Return
DuPont ROE decomposition for CTSH (quarterly period ending 2025-09-30)
ROE: 1.8154712605598806%
Net margin: 5.060018467220683%
Asset turnover: 0.2687478286763611
Equity multiplier (leverage): 1.3350339572635415
EBIT margin: 15.992613111726687%
Interest burden factor: 1.0242494226327945
Tax burden factor: 0.3089064261555806
ROE archetype: Low Return
DuPont ROE decomposition for CTSH (quarterly period ending 2025-12-31)
ROE: 4.332709280556299%
Net margin: 12.150759422463905%
Asset turnover: 0.2612550825454367
Equity multiplier (leverage): 1.3648702861727735
EBIT margin: 15.99474967185449%
Interest burden factor: 1.0293083235638922
Tax burden factor: 0.7380410022779044
ROE archetype: Low Return
DuPont ROE decomposition for CTSH (quarterly period ending 2026-03-31)
ROE: 4.401156799521325%
Net margin: 12.229817106964715%
Asset turnover: 0.2628180229170713
Equity multiplier (leverage): 1.3692783299537945
EBIT margin: 15.573619065213377%
Interest burden factor: 1.0284697508896796
Tax burden factor: 0.7635524798154556
ROE archetype: Low Return
DuPont ROE decomposition for CTT.AX (annual period ending 2022-06-30)
ROE: -110.90085333123585%
Net margin: -9.08232984380814%
Asset turnover: 3.861683382258805
Equity multiplier (leverage): 3.161993365849391
EBIT margin: -12.505089064616238%
ROE archetype: Low Return
DuPont ROE decomposition for CTT.AX (annual period ending 2023-06-30)
ROE: 62.7337605174655%
Net margin: 3.8357757172137075%
Asset turnover: 5.289776390512523
Equity multiplier (leverage): 3.09179579583264
EBIT margin: 5.879940456821038%
Interest burden factor: 0.8988254058885013
Tax burden factor: 0.7257799019936754
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTT.AX (annual period ending 2024-06-30)
ROE: 30.425729025569492%
Net margin: 1.4111734004000482%
Asset turnover: 6.174500059809845
Equity multiplier (leverage): 3.49187599281772
EBIT margin: 2.5135167371082363%
Interest burden factor: 1.0658083444200523
Tax burden factor: 0.5267681206955739
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTT.AX (annual period ending 2025-06-30)
ROE: -7.2882708392719335%
Net margin: -0.35652047963687766%
Asset turnover: 5.549588855531293
Equity multiplier (leverage): 3.6836572296726717
EBIT margin: -1.066528344217356%
ROE archetype: Low Return
DuPont ROE decomposition for CTW (annual period ending 2023-07-31)
ROE: 17.996743900055325%
Net margin: 5.399053219832152%
Asset turnover: 1.6441352262041584
Equity multiplier (leverage): 2.0273969730016326
EBIT margin: 8.87824974402276%
Interest burden factor: 0.9370520577517586
Tax burden factor: 0.6489728558339276
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CTW (annual period ending 2024-07-31)
ROE: 26.974577145215157%
Net margin: 8.736099311216787%
Asset turnover: 1.6012154456602123
Equity multiplier (leverage): 1.9283564385072758
EBIT margin: 9.727911069146982%
Interest burden factor: 1.2313521272085528
Tax burden factor: 0.7293159401270852
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CTW (annual period ending 2025-07-31)
ROE: 15.028602084206277%
Net margin: 4.236504818542424%
Asset turnover: 2.0204830954307442
Equity multiplier (leverage): 1.7557216308134276
EBIT margin: -1.1786153077134114%
Tax burden factor: 0.8690753857430398
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CU.TO (quarterly period ending 2025-03-31)
ROE: 3.3134618050741715%
Net margin: 22.027649769585253%
Asset turnover: 0.04498714652956298
Equity multiplier (leverage): 3.343685013170664
EBIT margin: 36.22119815668203%
Interest burden factor: 0.7811704834605598
Tax burden factor: 0.7785016286644951
ROE archetype: Low Return
DuPont ROE decomposition for CU.TO (quarterly period ending 2025-06-30)
ROE: 1.6175539631163562%
Net margin: 13.539192399049881%
Asset turnover: 0.03584194608496856
Equity multiplier (leverage): 3.3333002585784337
EBIT margin: 27.55344418052256%
Interest burden factor: 0.6077586206896551
Tax burden factor: 0.8085106382978724
ROE archetype: Low Return
DuPont ROE decomposition for CU.TO (quarterly period ending 2025-09-30)
ROE: 1.411091823967961%
Net margin: 12.878787878787875%
Asset turnover: 0.03239622617285691
Equity multiplier (leverage): 3.3820954723683907
EBIT margin: 28.409090909090907%
Interest burden factor: 0.5866666666666667
Tax burden factor: 0.7727272727272727
ROE archetype: Low Return
DuPont ROE decomposition for CU.TO (quarterly period ending 2025-12-31)
ROE: -4.757764740513563%
Net margin: -33.470648815653966%
Asset turnover: 0.03975511117787576
Equity multiplier (leverage): 3.5755747364008754
EBIT margin: -1.6477857878475797%
ROE archetype: Low Return
DuPont ROE decomposition for CU.TO (quarterly period ending 2026-03-31)
ROE: 3.3791525660382065%
Net margin: 20.940959409594097%
Asset turnover: 0.04388202959262384
Equity multiplier (leverage): 3.6772615379767566
EBIT margin: 36.254612546125465%
Interest burden factor: 0.7506361323155216
Tax burden factor: 0.7694915254237287
ROE archetype: Low Return
DuPont ROE decomposition for CUBEXTUB.NS (annual period ending 2022-03-31)
ROE: 3.8959573902323066%
Net margin: 1.808852039270234%
Asset turnover: 1.3964799689040235
Equity multiplier (leverage): 1.542326938107862
EBIT margin: 0.8623379421960474%
Interest burden factor: 2.1414316702819955
Tax burden factor: 0.9795380875202594
ROE archetype: Low Return
DuPont ROE decomposition for CUBEXTUB.NS (annual period ending 2023-03-31)
ROE: 4.015121905940817%
Net margin: 1.385821034581668%
Asset turnover: 1.901903422996911
Equity multiplier (leverage): 1.5233620306012672
EBIT margin: 1.636646476405031%
Interest burden factor: 1.3186964308558269
Tax burden factor: 0.6421070501782553
ROE archetype: Low Return
DuPont ROE decomposition for CUBEXTUB.NS (annual period ending 2024-03-31)
ROE: 5.911134812253156%
Net margin: 1.8059612937121532%
Asset turnover: 2.1684186099910203
Equity multiplier (leverage): 1.5094519760067695
EBIT margin: 2.508797912958409%
Interest burden factor: 0.9558600519930676
Tax burden factor: 0.7530927153568664
ROE archetype: Standard Business
DuPont ROE decomposition for CUBEXTUB.NS (annual period ending 2025-03-31)
ROE: 9.069559327278013%
Net margin: 2.4927345469438302%
Asset turnover: 2.158389908765403
Equity multiplier (leverage): 1.6856998630524043
EBIT margin: 3.1769955334731206%
Interest burden factor: 0.9520409125188536
Tax burden factor: 0.8241453573285145
ROE archetype: Standard Business
DuPont ROE decomposition for CUBEXTUB.NS (annual period ending 2026-03-31)
ROE: 8.92769180940543%
Net margin: 2.5881102965047544%
Asset turnover: 1.591126461847946
Equity multiplier (leverage): 2.1679622246355845
EBIT margin: 1.8547215244153326%
Interest burden factor: 1.8037516146545107
Tax burden factor: 0.7736193708420255
ROE archetype: Standard Business
DuPont ROE decomposition for CUE (annual period ending 2022-12-31)
ROE: -80.70704302548644%
Net margin: -4257.831325301205%
Asset turnover: 0.013638903191174698
Equity multiplier (leverage): 1.3897719314271795
EBIT margin: -4297.349397590361%
ROE archetype: Low Return
DuPont ROE decomposition for CUE (annual period ending 2023-12-31)
ROE: -98.73402940632693%
Net margin: -924.0983606557377%
Asset turnover: 0.07185252563590794
Equity multiplier (leverage): 1.4869851216830305
EBIT margin: -947.0309653916212%
ROE archetype: Low Return
DuPont ROE decomposition for CUE (annual period ending 2024-12-31)
ROE: -149.03268357027702%
Net margin: -437.9670507160547%
Asset turnover: 0.19818397157520726
Equity multiplier (leverage): 1.717004983145244
EBIT margin: -447.8626036394961%
ROE archetype: Low Return
DuPont ROE decomposition for CUE (annual period ending 2025-12-31)
ROE: -121.10810134073888%
Net margin: -772.7035468873372%
Asset turnover: 0.09254243699850813
Equity multiplier (leverage): 1.6936331975142838
EBIT margin: -770.3507543417438%
ROE archetype: Low Return
DuPont ROE decomposition for CUEX.V (annual period ending 2022-03-31)
ROE: -8.251558820843087%
Asset turnover: 0
Equity multiplier (leverage): 1.1404876842571903
ROE archetype: Low Return
DuPont ROE decomposition for CUEX.V (annual period ending 2023-03-31)
ROE: -2.673902827786006%
Asset turnover: 0
Equity multiplier (leverage): 1.0863742787153363
ROE archetype: Low Return
DuPont ROE decomposition for CULP (quarterly period ending 2025-01-31)
ROE: -6.917015926236379%
Net margin: -7.896197347520717%
Asset turnover: 0.4096507388969464
Equity multiplier (leverage): 2.138390611902766
EBIT margin: -4.271525079899718%
ROE archetype: Low Return
DuPont ROE decomposition for CULP (quarterly period ending 2025-04-30)
ROE: -3.533123028391167%
Net margin: -4.248252106698378%
Asset turnover: 0.38874564112782706
Equity multiplier (leverage): 2.1393554437718474
EBIT margin: -1.6751071289442931%
ROE archetype: Low Return
DuPont ROE decomposition for CULP (quarterly period ending 2025-07-31)
ROE: -0.4007390252153322%
Net margin: -0.4557021956560336%
Asset turnover: 0.4058786791788105
Equity multiplier (leverage): 2.16662763364473
EBIT margin: -3.730445246690734%
Tax burden factor: -0.20298769771529
ROE archetype: Low Return
DuPont ROE decomposition for CULP (quarterly period ending 2025-10-31)
ROE: -7.742237085783124%
Net margin: -8.093680688695914%
Asset turnover: 0.4228035110445318
Equity multiplier (leverage): 2.262464714026287
EBIT margin: -5.556182098417352%
ROE archetype: Low Return
DuPont ROE decomposition for CULP (quarterly period ending 2026-01-31)
ROE: -6.61227084878669%
Net margin: -7.155217345981445%
Asset turnover: 0.38995617921805514
Equity multiplier (leverage): 2.36980165114106
EBIT margin: -6.54852496612113%
ROE archetype: Low Return
DuPont ROE decomposition for CULP (quarterly period ending 2026-04-30)
ROE: -4.55843931399758%
Net margin: -4.343025395656975%
Asset turnover: 0.443605178243814
Equity multiplier (leverage): 2.366067888621184
EBIT margin: -2.9463611181062705%
ROE archetype: Low Return
DuPont ROE decomposition for CUM.DE (quarterly period ending 2025-03-31)
ROE: 7.100492857739537%
Net margin: 10.398825544409101%
Asset turnover: 0.25126802127201747
Equity multiplier (leverage): 2.7174839194720573
EBIT margin: 12.27061414240274%
Interest burden factor: 1.1136590229312064
Tax burden factor: 0.7609668755595345
ROE archetype: Standard Business
DuPont ROE decomposition for CUM.DE (quarterly period ending 2025-06-30)
ROE: 7.470616647882789%
Net margin: 10.737012611361795%
Asset turnover: 0.25881119928132956
Equity multiplier (leverage): 2.6883754628884238
EBIT margin: 12.8196228161518%
Interest burden factor: 1.105595667870036
Tax burden factor: 0.7575510204081632
ROE archetype: Standard Business
DuPont ROE decomposition for CUM.DE (quarterly period ending 2025-09-30)
ROE: 4.304801509375842%
Net margin: 6.721173500060118%
Asset turnover: 0.2449887329337084
Equity multiplier (leverage): 2.6143390705017135
EBIT margin: 11.566670674522063%
Interest burden factor: 0.8627858627858628
Tax burden factor: 0.6734939759036145
ROE archetype: Low Return
DuPont ROE decomposition for CUM.DE (quarterly period ending 2025-12-31)
ROE: 4.678186071078247%
Net margin: 7.2633552014995315%
Asset turnover: 0.2524323525062842
Equity multiplier (leverage): 2.5514977740888853
EBIT margin: 9.149484536082474%
Interest burden factor: 1.0128040973111396
Tax burden factor: 0.7838179519595448
ROE archetype: Low Return
DuPont ROE decomposition for CUM.DE (quarterly period ending 2026-03-31)
ROE: 5.078416728902166%
Net margin: 8.097165991902834%
Asset turnover: 0.24542279760948024
Equity multiplier (leverage): 2.5555265123226287
EBIT margin: 11.907597046915933%
Interest burden factor: 0.934
Tax burden factor: 0.728051391862955
ROE archetype: Standard Business
DuPont ROE decomposition for CVCE.L (annual period ending 2022-12-31)
ROE: -14.2596468564076%
Asset turnover: -0.07758824174020519
Equity multiplier (leverage): 1.001593170417364
ROE archetype: Low Return
DuPont ROE decomposition for CVCE.L (annual period ending 2023-12-31)
ROE: 13.354369748104858%
Net margin: 61.049033893896464%
Asset turnover: 0.21851653202422275
Equity multiplier (leverage): 1.0010604453914436
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CVCE.L (annual period ending 2024-12-31)
ROE: 7.882593646582088%
Net margin: 47.00231031406547%
Asset turnover: 0.16759824299752338
Equity multiplier (leverage): 1.0006460194391884
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CVCE.L (annual period ending 2025-12-31)
ROE: -2.265155516382569%
Net margin: -35.04323689548414%
Asset turnover: 0.06457974645537891
Equity multiplier (leverage): 1.0009156369309369
ROE archetype: Low Return
DuPont ROE decomposition for CVG.TO (quarterly period ending 2024-12-31)
ROE: 3.1150023210615476%
Net margin: 74.9804992199688%
Asset turnover: 0.03640344214138563
Equity multiplier (leverage): 1.1412153288899656
Tax burden factor: 0.8299158212821066
ROE archetype: Low Return
DuPont ROE decomposition for CVG.TO (quarterly period ending 2025-03-31)
ROE: 1.6670555202458626%
Net margin: 64.66219378998284%
Asset turnover: 0.022582064787869883
Equity multiplier (leverage): 1.1416578839392744
Tax burden factor: 0.9968728952179352
ROE archetype: Low Return
DuPont ROE decomposition for CVG.TO (quarterly period ending 2025-06-30)
ROE: 1.7353849526643232%
Net margin: 54.35369643857951%
Asset turnover: 0.02787264253853418
Equity multiplier (leverage): 1.1454828668781836
Tax burden factor: 0.8945161831292974
ROE archetype: Low Return
DuPont ROE decomposition for CVG.TO (quarterly period ending 2025-09-30)
ROE: -6.310133563198492%
Asset turnover: -0.061163194206905795
Equity multiplier (leverage): 1.142371022116722
ROE archetype: Low Return
DuPont ROE decomposition for CVG.TO (quarterly period ending 2025-12-31)
ROE: 8.785502400891877%
Net margin: 82.01587041501838%
Asset turnover: 0.0950025286677716
Equity multiplier (leverage): 1.1275441042611472
Tax burden factor: 0.8717221475842165
ROE archetype: Standard Business
DuPont ROE decomposition for CVG.TO (quarterly period ending 2026-03-31)
ROE: 4.857894503472602%
Net margin: 68.83231582782261%
Asset turnover: 0.06232502080818023
Equity multiplier (leverage): 1.1323828038360269
Tax burden factor: 0.879219900160758
ROE archetype: Low Return
DuPont ROE decomposition for CVGI (quarterly period ending 2025-03-31)
ROE: -3.1553682238613745%
Net margin: -2.5395329662239763%
Asset turnover: 0.404444253887948
Equity multiplier (leverage): 3.0721153846153846
EBIT margin: 0.8292352542772167%
Interest burden factor: -0.7265625
ROE archetype: Low Return
DuPont ROE decomposition for CVGI (quarterly period ending 2025-06-30)
ROE: -3.4093472399755096%
Net margin: -2.768731535974319%
Asset turnover: 0.40478474418473265
Equity multiplier (leverage): 3.042049332058677
EBIT margin: 0.46349066040149806%
Interest burden factor: -2.987452948557089
ROE archetype: Low Return
DuPont ROE decomposition for CVGI (quarterly period ending 2025-09-30)
ROE: -5.072323597051175%
Net margin: -4.642957852697572%
Asset turnover: 0.3674172558818108
Equity multiplier (leverage): 2.973395376161512
EBIT margin: -0.6957878928971926%
ROE archetype: Low Return
DuPont ROE decomposition for CVGI (quarterly period ending 2025-12-31)
ROE: -4.912480917727616%
Net margin: -4.283351210245409%
Asset turnover: 0.39082349405729194
Equity multiplier (leverage): 2.9345163107112686
EBIT margin: -1.1624300538891976%
ROE archetype: Low Return
DuPont ROE decomposition for CVGI (quarterly period ending 2026-03-31)
ROE: 0.6824415063647884%
Net margin: 0.5259628560599434%
Asset turnover: 0.4264649747657172
Equity multiplier (leverage): 3.0424747961943672
EBIT margin: 0.44082917869325633%
Interest burden factor: 3.6984126984126986
Tax burden factor: 0.32260371959942774
ROE archetype: Low Return
DuPont ROE decomposition for CVN.AX (annual period ending 2022-06-30)
ROE: -19.910140826289545%
Equity multiplier (leverage): 1.0136048122439607
ROE archetype: Low Return
DuPont ROE decomposition for CVN.AX (annual period ending 2023-06-30)
ROE: -1.4962434004479235%
Equity multiplier (leverage): 1.0110355004732257
ROE archetype: Low Return
DuPont ROE decomposition for CVN.AX (annual period ending 2024-06-30)
ROE: -0.24711585491593058%
Equity multiplier (leverage): 1.006515642496483
ROE archetype: Low Return
DuPont ROE decomposition for CVN.AX (annual period ending 2025-06-30)
ROE: 1.343542934131344%
Equity multiplier (leverage): 1.0111823347189977
Tax burden factor: 0.49646258503401364
ROE archetype: Low Return
DuPont ROE decomposition for CVSA (annual period ending 2022-06-30)
ROE: 20.852482187709956%
Net margin: 22.50553970714452%
Asset turnover: 0.45601734516077935
Equity multiplier (leverage): 2.031828111568702
EBIT margin: 11.2583059423581%
Interest burden factor: -0.33099786593988634
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CVSA (annual period ending 2023-06-30)
ROE: 6.3320991263333735%
Net margin: 6.434817131758047%
Asset turnover: 0.4967917817839772
Equity multiplier (leverage): 1.980783878575193
EBIT margin: 14.910885247438355%
Interest burden factor: 0.517886941769788
Tax burden factor: 0.8332931673137859
ROE archetype: Standard Business
DuPont ROE decomposition for CVSA (annual period ending 2024-06-30)
ROE: 9.678287872049633%
Net margin: 8.631358809378968%
Asset turnover: 0.5708443759841123
Equity multiplier (leverage): 1.9642720551528743
EBIT margin: 15.974422144420352%
Interest burden factor: 0.6476165268883893
Tax burden factor: 0.8343266010723631
ROE archetype: Standard Business
DuPont ROE decomposition for CVSA (annual period ending 2025-06-30)
ROE: 16.916539411151867%
Net margin: 13.256518797286793%
Asset turnover: 0.6510248246695484
Equity multiplier (leverage): 1.960128230743981
EBIT margin: 19.284120584468962%
Interest burden factor: 0.8656192729719071
Tax burden factor: 0.7941503581071575
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CVU (quarterly period ending 2025-03-31)
ROE: -5.3106620830294275%
Net margin: -8.596569693871826%
Asset turnover: 0.2356247821034927
Equity multiplier (leverage): 2.6218178372836056
EBIT margin: -7.702955623570186%
ROE archetype: Low Return
DuPont ROE decomposition for CVU (quarterly period ending 2025-06-30)
ROE: -5.441006393113419%
Net margin: -8.72883307767492%
Asset turnover: 0.22059979959699366
Equity multiplier (leverage): 2.8256471846191418
EBIT margin: -13.114354282214737%
ROE archetype: Low Return
DuPont ROE decomposition for CVU (quarterly period ending 2025-09-30)
ROE: 4.567845939809164%
Net margin: 5.7796777452317185%
Asset turnover: 0.2633974444841974
Equity multiplier (leverage): 3.00051820835138
EBIT margin: 9.107632519668016%
Interest burden factor: 0.7789566593863446
Tax burden factor: 0.8146758280865843
ROE archetype: Low Return
DuPont ROE decomposition for CVU (quarterly period ending 2025-12-31)
ROE: 2.723920161416966%
Net margin: 3.5636897703049653%
Asset turnover: 0.26005677153589074
Equity multiplier (leverage): 2.939180902171035
EBIT margin: 6.416233278350426%
Interest burden factor: 0.6698297932808447
Tax burden factor: 0.8291923455849041
ROE archetype: Low Return
DuPont ROE decomposition for CVU (quarterly period ending 2026-03-31)
ROE: 4.6591988084198075%
Net margin: 7.123976234940904%
Asset turnover: 0.22759699839688433
Equity multiplier (leverage): 2.8735731034587597
EBIT margin: 10.539368223622892%
Interest burden factor: 0.8570408848137435
Tax burden factor: 0.7886900168742897
ROE archetype: Low Return
DuPont ROE decomposition for CVVY.TO (quarterly period ending 2025-03-31)
ROE: 2.0037128061749834%
Net margin: 4.437195213288284%
Asset turnover: 0.10513762752200466
Equity multiplier (leverage): 4.295055353881537
EBIT margin: -15.012565950435231%
Tax burden factor: 0.6394818901415207
ROE archetype: Low Return
DuPont ROE decomposition for CVVY.TO (quarterly period ending 2025-06-30)
ROE: 2.8917458184971023%
Net margin: 6.959805320130906%
Asset turnover: 0.10826665587810537
Equity multiplier (leverage): 3.8376759632677424
EBIT margin: -21.283880171184023%
Tax burden factor: 0.8030596436870644
ROE archetype: Low Return
DuPont ROE decomposition for CVVY.TO (quarterly period ending 2025-09-30)
ROE: -6.732522948150664%
Net margin: -21.595118295685687%
Asset turnover: 0.08510648797037736
Equity multiplier (leverage): 3.663191188260954
EBIT margin: -48.001284659030084%
ROE archetype: Low Return
DuPont ROE decomposition for CVVY.TO (quarterly period ending 2025-12-31)
ROE: -1.1642557315111661%
Net margin: -2.5643494447653894%
Asset turnover: 0.11673009322412248
Equity multiplier (leverage): 3.8894513703927114
EBIT margin: -1.8951794081776754%
Tax burden factor: -0.36096679466907616
ROE archetype: Low Return
DuPont ROE decomposition for CVVY.TO (quarterly period ending 2026-03-31)
ROE: 2.3996723970368494%
Net margin: 4.089038879386067%
Asset turnover: 0.15950967995090018
Equity multiplier (leverage): 3.679117620637679
EBIT margin: 12.457815172668854%
Interest burden factor: 0.6343816680582615
Tax burden factor: 0.5174027493419129
ROE archetype: Low Return
DuPont ROE decomposition for CWCO (quarterly period ending 2025-03-31)
ROE: 2.2651705954582417%
Net margin: 14.700873206697773%
Asset turnover: 0.1346627965650615
Equity multiplier (leverage): 1.1442216324190382
EBIT margin: 13.591207693461014%
Interest burden factor: 1.1565418276474315
Tax burden factor: 0.9352414327425904
ROE archetype: Low Return
DuPont ROE decomposition for CWCO (quarterly period ending 2025-06-30)
ROE: 2.3697766027738316%
Net margin: 15.556460690054047%
Asset turnover: 0.1322815345085811
Equity multiplier (leverage): 1.1515886800524273
EBIT margin: 15.634350417859455%
Interest burden factor: 1.1622696218991508
Tax burden factor: 0.8560991529086267
ROE archetype: Low Return
DuPont ROE decomposition for CWCO (quarterly period ending 2025-09-30)
ROE: 2.5460190326461283%
Net margin: 16.254243536194075%
Asset turnover: 0.1364526846287031
Equity multiplier (leverage): 1.1479231090191704
EBIT margin: 16.30808094125108%
Interest burden factor: 1.147598114047961
Tax burden factor: 0.868508510220374
ROE archetype: Low Return
DuPont ROE decomposition for CWCO (quarterly period ending 2025-12-31)
ROE: 1.3423122411675992%
Net margin: 10.25199912655737%
Asset turnover: 0.11518336508459615
Equity multiplier (leverage): 1.136724519401736
EBIT margin: 9.110907853489106%
Interest burden factor: 1.2620319707391474
Tax burden factor: 0.8916133229843363
ROE archetype: Low Return
DuPont ROE decomposition for CWCO (quarterly period ending 2026-03-31)
ROE: 1.7273941443160772%
Net margin: 13.123384834037841%
Asset turnover: 0.11579096733607223
Equity multiplier (leverage): 1.1367655312663563
EBIT margin: 11.666711150108261%
Interest burden factor: 1.195130606858272
Tax burden factor: 0.9412002854062373
ROE archetype: Low Return
DuPont ROE decomposition for CWEB.TO (annual period ending 2022-12-31)
ROE: -76.52796593768144%
Net margin: -80.00242787197021%
Asset turnover: 0.39510877095746155
Equity multiplier (leverage): 2.4210309012321787
EBIT margin: -68.31627078865374%
ROE archetype: Low Return
DuPont ROE decomposition for CWEB.TO (annual period ending 2023-12-31)
ROE: -35.7667854083059%
Net margin: -37.67872694165149%
Asset turnover: 0.37129251300743704
Equity multiplier (leverage): 2.556627737445702
EBIT margin: -63.43757422215185%
ROE archetype: Low Return
DuPont ROE decomposition for CWEB.TO (annual period ending 2024-12-31)
ROE: -72.22786893180388%
Net margin: -60.092214146213784%
Asset turnover: 0.3734501297041242
Equity multiplier (leverage): 3.2185034606263008
EBIT margin: -64.40292347031227%
ROE archetype: Low Return
DuPont ROE decomposition for CWEB.TO (annual period ending 2025-12-31)
ROE: -237.47205365697857%
Net margin: -59.60478585886927%
Asset turnover: 0.5288079908857272
Equity multiplier (leverage): 7.53413446183328
EBIT margin: -40.61967653365934%
ROE archetype: Low Return
DuPont ROE decomposition for CWT (annual period ending 2022-12-31)
ROE: 7.260392893494677%
Net margin: 11.343039184528921%
Asset turnover: 0.19846849088107732
Equity multiplier (leverage): 3.225069835465073
EBIT margin: 15.568546048053534%
Interest burden factor: 0.7712878575168656
Tax burden factor: 0.944636848422834
ROE archetype: Standard Business
DuPont ROE decomposition for CWT (annual period ending 2023-12-31)
ROE: 3.7716341665255935%
Net margin: 6.532709480614926%
Asset turnover: 0.17936816462923683
Equity multiplier (leverage): 3.2187767237038756
EBIT margin: 8.007857725337011%
Interest burden factor: 0.7008156145396257
Tax burden factor: 1.1640542661733377
ROE archetype: Low Return
DuPont ROE decomposition for CWT (annual period ending 2024-12-31)
ROE: 12.436102741382221%
Net margin: 18.403346431251364%
Asset turnover: 0.21211651283125624
Equity multiplier (leverage): 3.1857597508699413
EBIT margin: 25.316500869015034%
Interest burden factor: 0.8860535729932986
Tax burden factor: 0.8204141477551231
ROE archetype: Standard Business
DuPont ROE decomposition for CWT (annual period ending 2025-12-31)
ROE: 7.699756865903303%
Net margin: 12.819305297258385%
Asset turnover: 0.18433300330057334
Equity multiplier (leverage): 3.258437702029961
EBIT margin: 18.306637070810087%
Interest burden factor: 0.8026238175343543
Tax burden factor: 0.8724566871265839
ROE archetype: Standard Business
DuPont ROE decomposition for CXH (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.6108768199656345
ROE archetype: Standard Business
DuPont ROE decomposition for CXH (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.634243494330366
ROE archetype: Standard Business
DuPont ROE decomposition for CXH (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.6467285075141815
ROE archetype: Standard Business
DuPont ROE decomposition for CXI.TO (annual period ending 2022-10-31)
ROE: 17.00171338471809%
Net margin: 17.4568231882129%
Asset turnover: 0.5377144989288198
Equity multiplier (leverage): 1.8112388728001405
EBIT margin: 28.28559607386652%
Interest burden factor: 0.7444090586401858
Tax burden factor: 0.8290643267077135
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CXI.TO (annual period ending 2023-10-31)
ROE: 13.725071528598413%
Net margin: 12.437966849738787%
Asset turnover: 0.6363484551003051
Equity multiplier (leverage): 1.7340843844581966
EBIT margin: 20.825632490038497%
Interest burden factor: 0.8510151310679376
Tax burden factor: 0.7018008872420487
ROE archetype: Standard Business
DuPont ROE decomposition for CXI.TO (annual period ending 2024-10-31)
ROE: 3.1191095475441575%
Net margin: 3.589381028449743%
Asset turnover: 0.523696339957306
Equity multiplier (leverage): 1.659325266929616
EBIT margin: 28.65885952339338%
Interest burden factor: 0.9091613505139159
Tax burden factor: 0.13775890886502618
ROE archetype: Low Return
DuPont ROE decomposition for CXI.TO (annual period ending 2025-10-31)
ROE: 12.576916620374263%
Net margin: 14.24301593456623%
Asset turnover: 0.5746610821468104
Equity multiplier (leverage): 1.5365986073166549
EBIT margin: 29.26068023567272%
Interest burden factor: 0.9035785789067554
Tax burden factor: 0.5387057553811483
ROE archetype: Standard Business
DuPont ROE decomposition for CY1K.DE (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.5668569741100407
ROE archetype: Standard Business
DuPont ROE decomposition for CY1K.DE (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.400711216906699
ROE archetype: Standard Business
DuPont ROE decomposition for CYBE.V (quarterly period ending 2025-01-31)
Net margin: -325.7839257173301%
Asset turnover: 0.12240315999329247
EBIT margin: -336.5210442194992%
ROE archetype: Standard Business
DuPont ROE decomposition for CYBE.V (quarterly period ending 2025-04-30)
Net margin: -122.18595015380751%
Asset turnover: 0.1334403520097678
EBIT margin: -122.41430723837028%
ROE archetype: Standard Business
DuPont ROE decomposition for CYBE.V (quarterly period ending 2025-07-31)
Net margin: -10473.241397599946%
Asset turnover: 0.04309038706021836
EBIT margin: -9163.738425158568%
ROE archetype: Standard Business
DuPont ROE decomposition for CYBE.V (quarterly period ending 2025-10-31)
Net margin: -4908.227224346592%
Asset turnover: 0.04284611577757922
EBIT margin: -4908.268616706745%
ROE archetype: Standard Business
DuPont ROE decomposition for CYBE.V (quarterly period ending 2026-01-31)
Net margin: -2630.8596723715004%
Asset turnover: 0.06763077756230204
EBIT margin: -2630.940028759128%
ROE archetype: Standard Business
DuPont ROE decomposition for CYBE.V (quarterly period ending 2026-04-30)
Net margin: -3454.874824104285%
Asset turnover: 0.0428417213403366
EBIT margin: -3454.879463112156%
ROE archetype: Standard Business
DuPont ROE decomposition for CYG.AX (annual period ending 2022-06-30)
ROE: 4.261781303096196%
Net margin: 1.5019049155508124%
Asset turnover: 1.1561202017231114
Equity multiplier (leverage): 2.454402197357185
EBIT margin: 3.18809644953525%
Interest burden factor: 0.7144803425457377
Tax burden factor: 0.6593571233996187
ROE archetype: Low Return
DuPont ROE decomposition for CYG.AX (annual period ending 2023-06-30)
ROE: 2.1380169767280393%
Net margin: 0.6894570525711002%
Asset turnover: 1.2511719192357658
Equity multiplier (leverage): 2.478488694468761
EBIT margin: 7.581238512535456%
Interest burden factor: 0.13696563902582592
Tax burden factor: 0.6639806607574537
ROE archetype: Low Return
DuPont ROE decomposition for CYG.AX (annual period ending 2024-06-30)
ROE: 0.516303962212251%
Net margin: 0.17772144388560024%
Asset turnover: 1.1765906569024331
Equity multiplier (leverage): 2.4691088125815686
EBIT margin: 7.822710049756611%
Interest burden factor: 0.03692212224635433
Tax burden factor: 0.6153127917833799
ROE archetype: Low Return
DuPont ROE decomposition for CYG.AX (annual period ending 2025-06-30)
ROE: -22.987794107455624%
Net margin: -8.105521243568788%
Asset turnover: 1.065321764698836
Equity multiplier (leverage): 2.66216856217123
EBIT margin: 0.4774729313163004%
Interest burden factor: -18.593337162550256
ROE archetype: Low Return
DuPont ROE decomposition for CYL.AX (annual period ending 2021-06-30)
ROE: -0.18995275796418393%
Net margin: -0.35933053628366407%
Asset turnover: 0.34528838788116967
Equity multiplier (leverage): 1.5309799558592223
EBIT margin: 4.225358238770005%
Interest burden factor: -0.08504143695713352
ROE archetype: Low Return
DuPont ROE decomposition for CYL.AX (annual period ending 2022-06-30)
ROE: 3.685733078904833%
Net margin: 3.3025167096215315%
Asset turnover: 0.7470253073496791
Equity multiplier (leverage): 1.4939757283173989
EBIT margin: 0.25517117529710714%
Interest burden factor: 12.942358029962687
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CYL.AX (annual period ending 2023-06-30)
ROE: -13.63952660809136%
Net margin: -24.39478293506819%
Asset turnover: 0.321122448555887
Equity multiplier (leverage): 1.7411319005237194
EBIT margin: -19.360690604278744%
ROE archetype: Low Return
DuPont ROE decomposition for CYL.AX (annual period ending 2024-06-30)
ROE: 12.875917767908525%
Net margin: 7.431217548751791%
Asset turnover: 0.9697359302654787
Equity multiplier (leverage): 1.7867538712456001
EBIT margin: 12.395036181367384%
Interest burden factor: 0.6448058227719244
Tax burden factor: 0.9297864782728816
ROE archetype: Standard Business
DuPont ROE decomposition for CYN.L (annual period ending 2021-06-30)
ROE: 46.03577901299873%
Net margin: 98.88795753003635%
Asset turnover: 0.40451343103643145
Equity multiplier (leverage): 1.1508511173353912
Tax burden factor: 0.9979322530922216
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CYN.L (annual period ending 2022-06-30)
ROE: 17.641393391557273%
Net margin: 96.89909694445589%
Asset turnover: 0.1596854417969194
Equity multiplier (leverage): 1.140112824222622
Tax burden factor: 0.9914771528627484
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CYN.L (annual period ending 2023-06-30)
ROE: 3.9251515231330676%
Net margin: 81.34908299658066%
Asset turnover: 0.04280991838139124
Equity multiplier (leverage): 1.1270919941497877
Tax burden factor: 0.9137569832402235
ROE archetype: Low Return
DuPont ROE decomposition for CYN.L (annual period ending 2024-06-30)
ROE: 6.6340513074009735%
Net margin: 86.3959102527691%
Asset turnover: 0.06819150172367044
Equity multiplier (leverage): 1.1260440670819916
Tax burden factor: 0.9488459139114162
ROE archetype: Standard Business
DuPont ROE decomposition for CZN.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0099977013961374
ROE archetype: Standard Business